{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:01:43Z","timestamp":1792688503919,"version":"4.5.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.juro.2013.02.018","type":"journal-article","created":{"date-parts":[[2013,2,15]],"date-time":"2013-02-15T01:16:19Z","timestamp":1360890979000},"page":"64-69","source":"Crossref","is-referenced-by-count":110,"title":["PCA3 Molecular Urine Test as a Predictor of Repeat Prostate Biopsy Outcome in Men with Previous Negative Biopsies: A Prospective Multicenter Clinical Study"],"prefix":"10.1097","volume":"190","author":[{"given":"Marc C.","family":"Gittelman","sequence":"first","affiliation":[{"name":"South Florida Medical Research, Aventura, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Hertzman","sequence":"additional","affiliation":[{"name":"TriState Urological Services, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Bailen","sequence":"additional","affiliation":[{"name":"Metropolitan Urology, Jeffersonville, Indiana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Williams","sequence":"additional","affiliation":[{"name":"Florida Urology Specialists, Sarasota, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Koziol","sequence":"additional","affiliation":[{"name":"Virginia Urology, Richmond, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph Jonathan","family":"Henderson","sequence":"additional","affiliation":[{"name":"Regional Urology, Shreveport, Louisiana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"Efros","sequence":"additional","affiliation":[{"name":"AccuMed Research Associates, Garden City, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Bidair","sequence":"additional","affiliation":[{"name":"San Diego Clinical Trials, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Ward","sequence":"additional","affiliation":[{"name":"University of Texas M.D. Anderson Cancer Center, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2013.02.018_bib1","series-title":"Cancer Facts and Figures","year":"2012"},{"key":"10.1016\/j.juro.2013.02.018_bib2","doi-asserted-by":"crossref","first-page":"120","DOI":"10.7326\/0003-4819-157-2-201207170-00459","article-title":"Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement","volume":"157","author":"Moyer","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.juro.2013.02.018_bib3","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0022-5347(17)35233-3","article-title":"Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men","volume":"151","author":"Catalona","year":"1994","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2013.02.018_bib4","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1111\/j.1464-410X.2008.08214.x","article-title":"Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial","volume":"102","author":"Grubb","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2013.02.018_bib5","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1056\/NEJMoa0810084","article-title":"Screening and prostate-cancer mortality in a randomized European study","volume":"360","author":"Schr\u00f6der","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2013.02.018_bib6","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/S0022-5347(05)65652-2","article-title":"Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop?","volume":"166","author":"Djavan","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2013.02.018_bib7","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1016\/S0022-5347(05)64999-3","article-title":"Serial biopsy results in prostate cancer screening study","volume":"167","author":"Roehl","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2013.02.018_bib8","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.urology.2010.08.063","article-title":"Repeat prostate biopsy and the incremental risk of clinically insignificant prostate cancer","volume":"77","author":"Resnick","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.juro.2013.02.018_bib9","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0090-4295(02)01958-1","article-title":"Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program","volume":"60","author":"Raaijmakers","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.juro.2013.02.018_bib10","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.crad.2005.10.002","article-title":"Current status of transrectal ultrasound-guided prostate biopsy in the diagnosis of prostate cancer","volume":"61","author":"Raja","year":"2006","journal-title":"Clin Radiol"},{"key":"10.1016\/j.juro.2013.02.018_bib11","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.juro.2009.11.043","article-title":"Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy","volume":"183","author":"Nam","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2013.02.018_bib12","first-page":"5975","article-title":"DD3: a new prostate-specific gene, highly overexpressed in prostate cancer","volume":"59","author":"Bussemakers","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.juro.2013.02.018_bib13","first-page":"2695","article-title":"DD3(PCA3), a very sensitive and specific marker to detect prostate tumors","volume":"62","author":"de Kok","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.juro.2013.02.018_bib14","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0302-2838(03)00201-X","article-title":"DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer","volume":"44","author":"Hessels","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2013.02.018_bib15","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.urology.2006.12.014","article-title":"PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy","volume":"69","author":"Marks","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.juro.2013.02.018_bib16","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.juro.2007.11.038","article-title":"PCA3: a molecular urine assay for predicting prostate biopsy outcome","volume":"179","author":"Deras","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2013.02.018_bib17","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.eururo.2008.06.071","article-title":"Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy","volume":"54","author":"Haese","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2013.02.018_bib18","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.eururo.2010.06.039","article-title":"Performance of the prostate cancer antigen 3 (PCA3) gene and prostate-specific antigen in prescreened men: exploring the value of PCA3 for a first-line diagnostic test","volume":"58","author":"Roobol","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2013.02.018_bib19","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/j.juro.2010.06.098","article-title":"PCA3 molecular urine test for predicting repeat prostate biopsy outcome in populations at risk: validation in the placebo arm of the dutasteride REDUCE trial","volume":"184","author":"Aubin","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2013.02.018_bib20","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.juro.2008.01.013","article-title":"PCA3 molecular urine assay correlates with prostate cancer tumor volume: implication in selecting candidates for active surveillance","volume":"179","author":"Nakanishi","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2013.02.018_bib21","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.eururo.2010.10.024","article-title":"Critical assessment of preoperative urinary prostate cancer antigen 3 on the accuracy of prostate cancer staging","volume":"59","author":"Auprich","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2013.02.018_bib22","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.eururo.2010.11.044","article-title":"Prostate cancer antigen 3 score accurately predicts tumour volume and might help in selecting prostate cancer patients for active surveillance","volume":"59","author":"Ploussard","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2013.02.018_bib23","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/pcan.2011.52","article-title":"Utility of PCA3 in patients undergoing repeat biopsy for prostate cancer","volume":"15","author":"Wu","year":"2012","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.juro.2013.02.018_bib24","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1373\/clinchem.2005.063289","article-title":"APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer","volume":"52","author":"Groskopf","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.juro.2013.02.018_bib25","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"10.1016\/j.juro.2013.02.018_bib26","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/j.juro.2008.07.060","article-title":"PCA3 score before radical prostatectomy predicts extracapsular extension and tumor volume","volume":"180","author":"Whitman","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2013.02.018_bib27","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.juro.2010.11.072","article-title":"Urinary PCA3 score predicts prostate cancer multifocality","volume":"185","author":"Vlaeminck-Guillem","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2013.02.018_bib28","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/pros.20781","article-title":"Detailed analysis of histopathological parameters in radical prostatectomy specimens and PCA3 urine test results","volume":"68","author":"van Gils","year":"2008","journal-title":"Prostate"},{"key":"10.1016\/j.juro.2013.02.018_bib29","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/pros.21032","article-title":"Predictive value of PCA3 in urinary sediments in determining clinico-pathological characteristics of prostate cancer","volume":"70","author":"Hessels","year":"2010","journal-title":"Prostate"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534713002875?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534713002875?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2013.02.018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T02:48:58Z","timestamp":1651200538000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2013.02.018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["10.1016\/j.juro.2013.02.018"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2013.02.018","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}